CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
5 research outputs found
Effects of recombinant α-2b-interferon therapy in patients with progressive MS
Author
ANDERSON
Austims Research Group
+13Â more
CAMENGA
CUTLER
FARLOW
FARLOW
KNOBLER
KOOPMANS
NUWER
ORTALDO
PANITCH
PIRTTILĂ„
RICE
TIBBLING
TOURTELLOTTE
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up
Author
Austims Research Group
Camenga
+14Â more
Durelli
Filippi
Huber
IFNB MS Study Group
Jacobs
Jacobs
Kastrukoff
Knobler
Kurtzke
Milanese
Panitch
Paty DW Li DKB, The Ubc MS/MRI Study Group and the IFNB MS Study Group
Poser
Weiner
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Les traitements de première ligne dans la sclérose en plaques
Author
Amato
AUSTIMS Research Group
+94Â more
Baker
Bertolotto
Bertolotto
Brochet
Clanet
Clerico
Cohen
Cohen
Cohen
Comi
Comi
Comi
Deisenhammer
Durelli
Ebers
Edan
European Study Group on Interferon Beta-1b in Secondary Progressive MS
Farrell
Farrell
Ford
Francis
Goodin
Goodin
Hesse
Jacobs
Jacobs
Johnson
Kappos
Kappos
Kappos
Kappos
Kappos
Kappos
Kinkel
Le Page
Le Page
Le Page
Leary
Lebrun
Lebrun
Lebrun
Leray
Li
Li
Malucchi
Marriott
Mikol
Millefiorini
Miller
Noyes
Oturai
Outteryck
O’Connor
Pachner
Panitch
Panitch
Paty
Petersen
Petkau
Polman
Polman
Portaccio
Pozzilli
PRISMS
PRISMS Study Group
Prosperini
Rocher
Rudick
Rudick
Rudick
Rudick
Rudick
Rudick
Rudick
Rudick
RĂo
RĂo
RĂo
Sandberg-Wollheim
Sandberg-Wollheim
Schellekens
Schmit
Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group
Simon
Sorensen
Sorensen
The IFNB Multiple Sclerosis Study Group
The IFNB Multiple Sclerosis Study Group
van Baarsen
van der Voort
Verdun Di Cantogno
Walther
Waubant
Wolinsky
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Immunotherapy for multiple sclerosis.
Author
Abbruzzese G.
Achiron A.
+44Â more
Alam S.M.
Amato M.P.
Arnason B.G.W.
Barnes M.P.
Beck R.W.
Bornstein M.B.
Bornstein M.B.
Camenga D.L.
Carter J.L.
Cook S.D.
Cook S.D.
Edward M.K.
Francis D.A.
Gonzalez-Scarano F.
Group Austims Research
Group I.F.N.B.Multiple Sclerosis Study
Hafler D.A.
Hafler D.A.
Hauser S.L.
Huber S.J.
Jacobs L.
Khatri B.O.
Kinlen U.
Knobler R.L.
Kroemer G.
Likosky W.H.
MacFarland H.F.
Mackin G.A.
Milligan N.M.
Myers L.W.
Noronha A.
Panitch H.S.
Panitch H.S.
Paty D.W.
R A Hughes
Rose A.S.
Rudge P.
Thompson A.J.
Ventre J.J.
Weiner H.L.
Weiner H.L.
Wiles C.M.
Willoughby E.W.
Yudkin P.L.
Publication venue
'BMJ'
Publication date
Field of study
No full text
Crossref
Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis
Author
Alla L. Zozulya
Arne Skerra
+69Â more
AUSTIMS Research Group
Axtell
Baker
Baranzini
Begum
Borden
Calabresi
Croxford
Daniel Harari
Dhalluin
Ebers
Esashi
Fernald
Galligan
Gideon Schreiber
Goldman
Goverman
Guo
Harari
Heathcote
Hesse
Hu
Hundeshagen
IFNB Multiple Sclerosis Study Group
International Multiple Sclerosis Genetics Consortium (IMSGC)
International Multiple Sclerosis Genetics Consortium Wellcome Trust Case Control Consortium 2
Jaitin
Kalie
Karussis
Keren Sasson
Lavoie
Levin
Liu
Lublin
Lucchinetti
Mahmood
Mahurkar
Mario Köster
Martin Schlapschy
McFarland
Meerman
Mendel
Meyniel
Nadine Kuhn
Pachner
Paul Smith
Pestka
Platanias
Prinz
Pulverer
Raya Eilam
Renne Abramovich
Reuss
Rina Aharoni
Roisman
RĂo
Sandler
Schiweck
Schlapschy
Schlapschy
Schwid
Sellebjerg
Serana
Teige
Uzé
van der Meide
van der Voort
Vremec
Williams
Publication venue
'American Society for Biochemistry & Molecular Biology (ASBMB)'
Publication date
Field of study
No full text
Crossref